Y. Schlesinger

405 total citations
10 papers, 316 citations indexed

About

Y. Schlesinger is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Y. Schlesinger has authored 10 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Y. Schlesinger's work include Virus-based gene therapy research (4 papers), Hepatitis B Virus Studies (3 papers) and CAR-T cell therapy research (2 papers). Y. Schlesinger is often cited by papers focused on Virus-based gene therapy research (4 papers), Hepatitis B Virus Studies (3 papers) and CAR-T cell therapy research (2 papers). Y. Schlesinger collaborates with scholars based in France, Germany and Israel. Y. Schlesinger's co-authors include Andréa Pavirani, Valérie Legrand, Majid Mehtali, Danièle Spehner, Philippe Leissner, S. Cusack, Mark J. van Raaij, Annie Findeli, Philippe Ohlmann and Jacques Pouysségur and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Gut.

In The Last Decade

Y. Schlesinger

8 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y. Schlesinger France	5	238	166	129	60	59	10	316
Lilith Reeves United States	12	352 1.5×	419 2.5×	135 1.0×	36 0.6×	69 1.2×	22	535
Saswati Chatterjee United States	13	340 1.4×	376 2.3×	90 0.7×	32 0.5×	63 1.1×	18	516
Xiao Jin Yu United States	4	338 1.4×	329 2.0×	106 0.8×	38 0.6×	33 0.6×	4	438
Aurélien Jacob Italy	8	316 1.3×	488 2.9×	168 1.3×	47 0.8×	36 0.6×	10	575
Aphrodite Georgakopoulou United States	10	222 0.9×	307 1.8×	72 0.6×	33 0.6×	40 0.7×	16	394
Joseph R. McGill United States	10	69 0.3×	266 1.6×	76 0.6×	54 0.9×	16 0.3×	18	350
T. Faure France	8	148 0.6×	209 1.3×	36 0.3×	69 1.1×	33 0.6×	13	339
Sabine Knöß Germany	4	235 1.0×	282 1.7×	144 1.1×	24 0.4×	27 0.5×	4	400
Cordula Leurs Germany	7	136 0.6×	259 1.6×	45 0.3×	20 0.3×	36 0.6×	7	342
Emma J. West United Kingdom	10	196 0.8×	123 0.7×	189 1.5×	9 0.1×	40 0.7×	22	360

Countries citing papers authored by Y. Schlesinger

Since Specialization

Citations

This map shows the geographic impact of Y. Schlesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Schlesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Schlesinger more than expected).

Fields of papers citing papers by Y. Schlesinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Schlesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Schlesinger. The network helps show where Y. Schlesinger may publish in the future.

Co-authorship network of co-authors of Y. Schlesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Schlesinger. A scholar is included among the top collaborators of Y. Schlesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Schlesinger. Y. Schlesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Silvestre, Nathalie, et al.. (2025). 385P VacDesignR®: A computational tool to optimize viral-based individualized neoantigen therapeutic vaccine production. 10. 100581–100581.

Bourgonje, Arno R., Sergio Andreu‐Sánchez, Ranko Gaćeša, et al.. (2025). Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset. Gut. 74(12). 1977–1988.

Lélu, Karine, Roland Kratzer, Sarah Dion, et al.. (2015). O031 : TG1050, a novel immunotherapeutic to treat chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models. Journal of Hepatology. 62. S205–S205. 1 indexed citations

Schlesinger, Y., et al.. (2014). Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models. Vaccine. 32(26). 3256–3263. 4 indexed citations

Martin, P. J., Christophe Dubois, Sarah Dion, et al.. (2013). 130 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE AND HBV TOLERANT MICE. Journal of Hepatology. 58. S57–S58. 3 indexed citations

Miron, Dan, et al.. (2010). Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.. PubMed. 12(5). 277–9. 5 indexed citations

Foloppe, Johann, Jacqueline Kintz, Annie Findeli, et al.. (2008). Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus. Gene Therapy. 15(20). 1361–1371. 83 indexed citations

Leissner, Philippe, Valérie Legrand, Y. Schlesinger, et al.. (2001). Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Therapy. 8(1). 49–57. 78 indexed citations

Legrand, Valérie, et al.. (1999). Fiberless Recombinant Adenoviruses: Virus Maturation and Infectivity in the Absence of Fiber. Journal of Virology. 73(2). 907–919. 74 indexed citations

10.

Rasmussen, Ulla, Christian Gachet, Y. Schlesinger, et al.. (1993). A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. Journal of Biological Chemistry. 268(19). 14322–14328. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact